presents

the

OLAM Study

Lisdexamphetamine

for the treatment of

Methamphetamine withdrawal

safety and feasibility study

 
Watch now!
 
 
 
 
 

the VAN series are bitesize videos showcasing NCCRED supported research produced for consumers & professionals with the generous support of our partners at Insight

learn more at www.nccred.org.au

 
More Information about the OLAM study

The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions 

 
 
 
 
 
 
  Tweet 
  Forward 
National Centre for Clinical Research on Emerging Drugs (NCCRED)
You are receiving this email because you have previously signed up for our newsletter, you have expressed an interest in NCCRED, or because you have been identified as a potential stakeholder.
Please unsubscribe if you no longer wish to receive these emails. 
Preferences  |  Unsubscribe